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Filamentous bacteriophages Pf1 and Pf3 infect Pseudomonas aeruginosa strains K and O, respectively. We show here that the capsids of these
bacteriophages each contain a few copies of a minor coat protein (designated g3p) of high molecular mass, which serves as a pilus adsorption
protein, much like the protein g3p of the Ff bacteriophages which infect Escherichia coli. Bacteriophage Pf1 was observed to interact with the
type IV PAK pilus whereas bacteriophage Pf3 interacted with the conjugative RP4 pilus and not with the type IV PAO pilus. The specificity was
found to be mediated by their pilus-binding proteins. This is evidence of a conserved pathway of infection among different classes of filamentous
bacteriophage. However, there are likely to be subtle differences yet to be discovered in the way these virions effect entry into their targeted
bacterial cells.
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The filamentous bacteriophages of the genus Inovirus are a
family of viruses containing circular, single-stranded DNA
which infect Gram-negative bacteria by means of an initial
attachment to the bacterial pilus. Infection by all known
filamentous bacteriophages results in the extrusion of progeny
virions into the medium without host cells lysis (for a review
see Model and Russel, 1988; Webster, 1996). The rod shaped
virions consist of a helical sheath of several thousand major
coat protein (g8p) subunits, together with some minor coat
proteins, surrounding the relevant phage DNA molecule.
The Inoviruses are subdivided into two classes according to
the helical arrangement of the subunits in their protein capsids,
the structures of which have been determined by X-ray fiber
diffraction and NMR spectroscopy (Marvin et al., 1974;
Pederson et al., 2001; Thiriot et al., 2004; Welsh et al., 1998,
2000). Class I bacteriophages are characterized by a coat0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Trias i Pujol. Ctra. Canyet s/n, 08916 Badalona, Spain.protein symmetry designated by a five-fold rotation axis
combined with a two-fold screw axis, and include strains fd,
M13 and f1 (almost identical); as the initial step in the infection
process, these virions attach to the F pilus of Escherichia coli
and are collectively known as the Ff bacteriophages. Class II
members include bacteriophages Pf1 and Pf3 which infect
Pseudomonas aeruginosa strains K and O, respectively. They
differ from those of class I in having their coat protein subunits
arranged as a single-start helix, with approximately 5.4
subunits per turn. They too adsorb to the pili of their bacterial
host cell to initiate infection. Attachment of the Ff bacterio-
phages to the E. coli bacterial cell is mediated by an interaction
of the minor coat protein, g3p, located at one tip of the virion,
with the tip of the host F pilus (Gray et al., 1981). After
retraction of the pilus with the virion attached, the Ff
bacteriophage DNA is translocated into the cytoplasm of the
host cell while the major coat protein, g8p, becomes inserted
into the host cell inner membrane. The translocation process
requires an interaction of the bacteriophage Ff g3p with the
host TolQRA protein complex of the inner membrane (Click
and Webster, 1997; Riechmann and Holliger, 1997).
The g3p of the Class I Ff bacteriophages has been shown to
consist of three globular domains: (from the N-terminus) the
D1 penetration domain, the D2 pilus adsorption domain and6) 540 – 548
www.e
Fig. 1. Characterization of the Pf3 virion by SDS-PAGE and N-terminal
sequence analysis. From left: lane 1—M12 marker proteins (Novagen); Lane
2—4.5 Ag bacteriophage Pf3; Lane 3—2 Ag bacteriophage Pf3. Pf3 virions
were solubilized by the addition of SDS sample buffer containing 50 AM DTT
and boiling for 5 min. Samples were then run on a 16% Tris–Glycine gel
which was stained with Coomassie Blue. N-terminal sequences are indicated
below the band labels.
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These domains are joined together by glycine-rich linker
regions. The D2 domain of the Ff g3p has been shown to be
responsible for the interaction of the bacteriophage with the tip
of the host (F) pilus (Deng et al., 1999; Riechmann and
Holliger, 1997). Retraction of the host pilus brings the g3p D1
domain into contact with domain III of the TolA protein in the
host cell membrane and their ensuing interaction is required for
infection to take place (Sun and Webster, 1987). The structure
of Ff g3p D1–D2 has been elucidated both alone and as a D1–
TolA complex (Holliger and Reichmann, 1997; Holliger et al.,
1999; Lubkowski et al., 1998, 1999), and the residues of D2
crucially involved in the interaction of g3p with the bacterial F
pilus have been delineated (Deng and Perham, 2002).
The infection mechanism of the class II filamentous
bacteriophages of P. aeruginosa has not been studied.
Although the capsids of bacteriophages Pf1 and Pf3 share the
same helical symmetry, the packaging of DNA in the two
virions is quite different (2.4 nucleotides per g8p subunit for
Pf3–identical to the Class I bacteriophage fd–compared with
1.0 nucleotide per subunit for Pf1). The Pf1 (Hill et al., 1991)
and Pf3 (Luiten et al., 1985) genomes have virtually no DNA
sequence homology with each other or with the genomes of the
Ff bacteriophages, although similarities do exist with the
overall organization of the ORFs in the Ff genomes.
This paper describes the identification of ORFs encoding
the pilus adsorption proteins (the counterparts of the g3p of Ff
bacteriophages) of both bacteriophages Pf1 and Pf3. The genes
encoding them have been expressed in E. coli and the
specificity of the expressed proteins for the PAK and PAO
pili of P. aeruginosa have been studied. The protein products
were tested for pilus binding both by direct ELISA-type
binding assays and by their ability to inhibit binding of intact
virions to their host pili. Bacteriophage Pf1 was shown to bind
to the type IV PAK pilus. In contrast, the pilus to which
bacteriophage Pf3 binds was identified as the RP4 pilus, a
conjugative pilus, and not the type IV PAO pilus.
Results
Identification of bacteriophage Pf3 minor coat protein
When intact bacteriophage Pf3 virions were subjected to
SDS-PAGE, two protein bands were clearly visible on
Coomassie-stained gels: a dense band at an apparent molecular
mass of about 5 kDa and a much fainter band at an apparent
molecular mass of 55 kDa (Fig. 1). The lower molecular mass
band was identified as the major coat protein, equivalent to Ff
g8p, as indicated by its N-terminal sequence (MQSVITDVTG-)
(Luiten et al., 1983) determined by automated amino acid
sequence analysis. The 55 kDa band, by analogy to the
appearance of Ff bacteriophage virions subjected to SDS-
PAGE, was thought likely to be the counterpart of their
attachment protein, g3p. Automated amino acid sequence
analysis of the 55 kDa band showed it to have an N-terminal
sequence of AGPVSTEVAA-. This corresponds to amino
acids 21–30 of a predicted protein that is encoded by ORF483of the Pf3 genome (Luiten et al., 1985). The program, SignalP
(http://genome.cbs.dtu.dk, Nielsen et al., 1997), used to predict
N-terminal signal sequences, indicates a possible leader
peptide comprising the first 20 amino acids of the protein
encoded by ORF483, with a cleavage site between Ala20 and
Ala21. Thus, our N-terminal sequence data are consistent with
the 55 kDa component of the Pf3 virion being a minor coat
protein encoded by ORF 483, generated from a proprotein by
post-translational removal of a 20-amino acid signal peptide.
This is similar to the g3p of Class I filamentous bacterio-
phages, which have an 18-residue leader peptide that is
similarly removed post-translationally (Model and Russel,
1988; Webster, 1996).
Treatment of Pf3 virions with subtilisin
In negatively-stained electron micrographs of the bacterio-
phage fd, the pilus-binding g3p exhibits a Fknob-on-stem_
structure, the knobs of which can be cleaved from the virion by
exposure to the proteinase subtilisin under non-denaturing
conditions. The resulting virion is otherwise intact but non-
infectious, and the globular domains released by proteolysis (in
the form of a 38 kDa soluble protein) constitute the N-terminal
portion of g3p and contain the pilus-binding site (Armstrong et
al., 1981). If the ORF483 protein of Pf3 is similarly arranged in
the virion, it was conceivable that subtilisin would release a
pilus-binding segment from this protein also; any effect this
might have on the ability of bacteriophage Pf3 to cause
infection should then become evident.
Virions of filamentous bacteriophages Pf3 and fd were
subjected to limited proteolysis with subtilisin under non-
denaturing conditions at pH 8.0 and 37 -C, as described in
Materials and methods. When subjected to SDS-PAGE, the
treated Pf3 virions no longer showed any 55 kDa coat protein
whereas the major coat protein band appeared unaffected (Fig.
2a), indicating that the putative g3p protein had been digested
by subtilisin. The g3p band had likewise disappeared from the
Fig. 2. Subtilisin treatment of filamentous bacteriophage virions. Bacterio-
phages Pf3 and fd were treated with subtilisin for 1 h at 37 -C. (a) Coomassie
Blue-stained SDS-PAGE analysis of both bacteriophages before and after
treatment with subtilisin. The identity of all bands was confirmed by N-terminal
sequence analysis. (b) Table showing p.f.u./ml for both bacteriophages before
and after treatment with subtilisin.
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apparent effect on its major coat protein. Any digestion
products, in both the Pf3 and fd samples, were at too low a
level to be detected by Coomassie Blue staining.
The subtilisin-treated bacteriophage Pf3 virions were found
by means of a plaque assay on P. aeruginosa to be 5 orders of
magnitude less infectious than untreated bacteriophage Pf3;
likewise, subtilisin-treated bacteriophage fd virions were 4
orders of magnitude less infectious than their untreated
counterparts when assayed with E. coli as host (Fig. 2b). In
negatively-stained electron micrographs, the overall appear-
ance of both bacteriophages Pf3 and Ff virions was unchanged
by the exposure to subtilisin (data not shown), indicating that
the observed loss of infectivity was not due to any discernible
disruption of the capsids. The relatively low resolution of the
electron microscopy did not allow a clear view of a knob-on-
stem structure at one end of either the Pf3 or fd virions.Fig. 3. Predicted amino acid sequences from ORF483 (Pf3) and ORF437 (Pf1). T
sequences are shown in bold text. The underlined letters indicate areas rich in glycine
trans-membrane anchor regions are boxed.Cloning and expression of ORF483 DNA
A comparison of the predicted amino acid sequence of the
protein encoded by Pf3 ORF483 with that of the g3p of
bacteriophage fd using hydropathicity and side chain electron
density profiles, revealed little similarity other than the
presence of very hydrophobic N- and C-terminal regions.
These hydrophobic regions correspond to the signal peptide at
the N-terminus of the proproteins and a trans-membrane anchor
at the C-terminal end. A prediction of trans-membrane helices
in the ORF483 protein sequence using the program TMHMM
(Krogh et al., 2001; Sonnhammer et al., 1998) indicated that
residues Gly459–Val481 at the C-terminal end are likely to
form a trans-membrane helix, closely resembling the C-
terminal trans-membrane anchor in the g3p of Ff virions
(Davis et al., 1985). The conspicuously long (and flexible) Gly-
rich linker regions that join the N-terminal globular domains of
g3p in Ff virions were not obvious in the primary structure
inferred from ORF483 DNA sequence; however, there is a
short span of 16 amino acids between residues Pro363 and
Ser378 of the ORF483 protein which could conceivably
encode some kind of linker (Fig. 3).
The C-terminal portion of both Pf3 ORF483 protein and Ff
g3p is very hydrophobic, and a soluble full-length recombinant
protein has hitherto proved difficult to obtain. For this reason,
and given that the C-terminal portion of the protein has been
shown to play no part in adsorption of Ff g3p to the bacterial
pilus and the subsequent infection of the E. coli cell (Deng et
al., 1999), a subgene was constructed that encoded the N-
terminal region comprising residues 1–378 of Pf3 ORF483
protein fused to an additional C-terminal 6xHis tag to aid
purification. The subgene was over-expressed in E. coli and the
resulting protein purified by metal chelate and ion exchange
chromatography, as described in Materials and methods.
The recombinant ORF483 protein (rORF483) was correctly
processed, with the predicted signal sequence effectivelyhe sequences are shown in single letter amino acid code. The putative signal
and serine that could possibly form linkers. The residues that form the putative
Fig. 4. Pilus-binding specificity of putative g3p proteins of bacteriophages Pf1
and Pf3. Pili solutions (30 Ag/ml) were immobilized and binding of (a) Pf3
virions (10 Ag/ml) and rORF483 (3 AM) or (b) Pf1 virions (10 Ag/ml) and
rORF437 (3 AM) was tested. For detection, anti-Pf3 (a) and anti-Pf1 (b)
antibodies were applied followed by a secondary antibody–HRP conjugate.
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terminal sequence identical to the wild-type protein derived
from intact virions subjected to SDS-PAGE (see above).
Moreover, in ELISA and Western blot formats (data not
shown), the rORF483 protein was found to interact with
antibodies raised against wild-type Pf3 virions and which
interact with wild-type ORF483 protein.
Cloning and expression of ORF437 DNA
The pilus adsorption protein (g3p) of bacteriophage Pf1 was
identified in much the same way as that of Pf3: a minor high
molecular mass component of the Pf1 virion, observed in
Coomassie-stained SDS-PAGE, was analyzed by means of
automated N-terminal sequence analysis. Its N-terminal se-
quence, GPYIEWV-, was identified as arising from the putative
protein encoded by ORF437 of the Pf1 genome (Hill et al.,
1991). The mature protein in the virion is evidently formed of
residues 32–437 of the predicted ORF437 sequence, generated
by removal of a 31-amino acid leader peptide. One glycine-rich
region is readily apparent in the primary structure, spanning
residues 266–320 of the protein (Fig. 3). By comparison with
the domain and linker sequences of bacteriophage fd g3p, this
region is most likely to form a linker connecting a domain
equivalent to D3 to the rest of the protein. On this premise, a
subgene encoding amino acid residues 31–265 of ORF437
preceded by the fd g8p leader sequence at the N-terminus to
encourage expression into the E. coli periplasm and with a
6xHis tag at the C-terminus to aid purification, was created and
expressed in E. coli . The mature recombinant protein
(rORF437) was found to be present in both the cytoplasm
and periplasm, but N-terminal sequence analysis revealed that
only the fraction in the periplasm had been correctly processed
by removal of the N-terminal leader sequence. This rORF437
protein was shown to interact with antibodies raised against
wild-type bacteriophage Pf1 virions in ELISA and Western blot
formats (data not shown).
Pilus-binding specificity of putative g3p proteins
A direct ELISA assay was used to test the ability of
bacteriophage Pf3 and Pf1 virions and rORF483 and rORF437
proteins to bind specifically to different sorts of pili. An anti-
Pf3 or anti-Pf1 antiserum, which interacts with both the major
and minor coat proteins in the respective virions, was used to
detect viral proteins that had bound to a given pilus. In this
way, bacteriophage Pf3 and rORF483 were found to bind
specifically to RP4 pili and not to PAO or PAK pili (Fig. 4a).
Similarly, bacteriophage Pf1 and rORF437 were shown to bind
specifically to PAK pili, and exhibit no interaction with RP4 or
PAO pili (Fig. 4b). The assay value for intact virions is higher
than that for recombinant proteins owing to the fact that the
antibodies used bind to the many copies of the major coat
protein (g8p) on the virion as well as a few copies of the minor,
g3p equivalent, coat protein. To confirm that the results were
specific and concentration-dependent, another ELISA was
performed by coating the wells with one concentration ofRP4 or PAK pili, and applying various concentrations of
rORF483 or rORF437 proteins, respectively. Both proteins
were shown to bind pili in a concentration-dependent manner,
thus confirming their role as the pilus adsorption proteins of
bacteriophages Pf3 and Pf1 (Fig. 5).
Competition ELISA assays
To investigate whether these Fg3p_ proteins bind to the same
binding site on their respective pili as the intact bacteriophages,
a competition ELISAwas developed in which the ability of the
recombinant proteins to inhibit the binding of the intact virions
to their respective pili was tested. To study the effect of
increasing concentrations of rORF483 protein on the binding
of Pf3 virions to RP4 pili, a different protein detection system
was required as the anti-Pf3 antibody used in the direct ELISA
interacts with both intact Pf3 and rORF483 protein. Therefore,
the Pf3 virions used in this experiment were labeled with biotin
so that they could be detected by means of a streptavidin–HRP
complex. Biotinylated Pf3 virions were found to be no less
infective than wild-type Pf3 when tested by p.f.u. assay (data
not shown). A binding curve for biotinylated Pf3 virions
binding to RP4 pili was generated (data not shown) and a
biotinylated bacteriophage concentration of 5 Ag/ml was
chosen for the competition assay. The bacteriophage Pf3 and
rORF483 competition assays are plotted in Figs. 6a and b; in
both cases, the binding of biotinylated Pf3 to the pilus is
inhibited. Assuming 5 copies of ORF483 protein per Pf3 virion
(as observed for g3p in the fd virion), 35 times more rORF483
Fig. 6. Competition ELISA. Differing concentrations of wild-type Pf3 (a) o
rORF483 (b) were mixed with 5 Ag/ml biotinylated Pf3 virions before applying
the mixture to immobilized RP4 pili (30 Ag/ml). Bound biotinylated Pf3 was
detected using streptavidin–HRP. (c) Differing concentrations of wild-type Pf1
or Pf3 were mixed with 2.5 AM rORF437 before applying the mixture to
immobilized PAK pili. Bound rORF437 was detected using anti-His antibody
and a secondary antibody–HRP conjugate.
Fig. 5. Concentration-dependent binding of putative g3p proteins to their
respective pili. RP4 (a) or PAK (b) pili (30 Ag/ml) were immobilized onto
plastic plates and the binding of rORF483 (a) and rORF437 (b) at different
concentrations ranging from 0 to 10 Ag/ml was measured.
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inhibit completely the binding of biotinylated Pf3 virions to the
RP4 pilus. This could be due perhaps to steric effects: the Pf3
virion is very large and, on binding to the pilus, could block
interactions of other Pf3 virions with neighboring sites.
Increasing concentrations of wild-type bacteriophage fd, tested
as a control, gave little or no reduction in Pf3 binding (data not
shown).
It was not possible to repeat these assays with bacteriophage
Pf1 and rORF437 protein as it turned out that biotinylation of
Pf1 virions damaged their infectivity. Therefore, a variation on
the assay was developed whereby an anti-His tag antibody was
used to detect rORF437, rather than detection of biotinylated
Pf1 virions. Increasing amounts of wild-type Pf1 virions were
found to inhibit the binding of rORF437 protein to PAK pili,
whereas increasing amounts of Pf3 virions did not (Fig. 6c).
Discussion
The class II filamentous bacteriophages Pf1 and Pf3 infect
P. aeruginosa strains K and O, respectively. Despite the large
body of knowledge regarding the Class I Ff bacteriophages,
which they resemble, very little is known about the processes
by which bacteriophages Pf1 and Pf3 infect their target
bacteria. The aim of this work was to find the proteins in the
virions, if any, that are involved in the initial step of virusinfection as counterparts of the well-characterized g3p of Ff
bacteriophages.
When bacteriophages Pf1 and Pf3 were submitted to SDS-
PAGE, an intense Coomassie-staining band was seen migrating
at an apparent molecular mass of about 5 kDa, corresponding
to the major coat protein of the virion. A minor band of high
molecular mass could also be seen, corresponding to an as yet
uncharacterized minor coat protein. Our N-terminal sequence
data confirmed the prediction of Luiten et al. (1985) that the 55
kDa protein band observed in SDS-PAGE could be encoded by
ORF483 of the Pf3 genome. The mature protein was shown to
have an N-terminal sequence starting at Ala21, pointing to the
removal of a predicted 20-amino acid signal peptide. This
protein is a minor component of the Pf3 virion and limited
proteolysis of it in situ led to a loss of bacteriophage infectivity.
This strongly suggests that the ORF483 protein is involved in
the Pf3 infection process, like the g3p of bacteriophage fd.
Similarly, a minor coat protein of high molecular mass inr
S.J. Holland et al. / Virology 345 (2006) 540–548 545bacteriophage Pf1 was shown to be encoded by ORF437 in its
genome, confirming the prediction of Hill et al. (1991) that
ORF437 was likely to encode such a protein.
There is no detectable sequence similarity between these
two proteins, or between either protein or the g3p of the Ff
bacteriophages. However, potential linker regions could be
identified in both Pf1 ORF437 protein and Pf3 ORF483
protein, with that of the Pf1 protein (residues 266–322) being
long and glycine-rich and thus resembling the linker regions
present in the g3p of the Ff bacteriophages. These linkers in the
Pf1 and Pf3 proteins most likely connect the functional
equivalents of the D1D2 and D3 domains of Ff g3p.
Having identified, cloned and expressed subgenes encoding
truncated forms of the g3p equivalents of bacteriophages Pf1
and Pf3, we found that the purified proteins bound specifically
to PAK and RP4 pili, respectively. This pilus specificity was
identical to that shown by the intact parent virions in identical
ELISA experiments. Although the bacterial host of bacterio-
phage Pf3 is P. aeruginosa strain O, no interaction was
observed between the Pf3 virion or the rORF483 protein and
the type IV PAO pilus. These results make it clear that
bacteriophage Pf3 infects its host via the conjugative pilus
encoded by the broad-host-range RP4 plasmid. This is in
contrast to bacteriophage Pf1, which infects its host (P.
aeruginosa strain K) via the type IV PAK pilus. Although
the closely related, chromosomally encoded PAK and PAO pili
have a similar overall structure, bacteriophage Pf1 exhibits no
interaction with the latter pilus. The two bacteriophages thus
use two very different types of pilus to accomplish the infection
of their P. aeruginosa host.
The identification of minor coat proteins that resemble the
Ff g3p in both Pf1 and Pf3 virions indicates similarities in these
diverse bacteriophages. The initial step in infection, the
adsorption of the virion to the host pilus by means of a minor
coat protein of high molecular mass, appears to be common to
all three bacteriophages, as well as to the bacteriophage CTXA
(Heilpern and Waldor, 2003). These virions infect different
bacteria, via different pili, and bacteriophage Pf3 may differ
further in binding to the side rather than the tip of its target
pilus (Bradley and Whelan, 1989). Nonetheless, although there
is no detectable sequence similarity between what have now
been identified as the g3p proteins in the various bacterio-
phages, a conservation of function is quite clear.
Material and methods
Bacterial cells and reagents
E. coli TG1 recO strain (K12, rk, mk, rb, mb) D (lac-
proAB), supE, thi, hsdD5, recO::Tn5 Kanr [FV traD36,
proA+B+, laqI q, lacZDM15] (Hawkins et al., 1990) was used
for expression of constructs encoding g3p proteins. P.
aeruginosa strains O and K (PAO and PAK) were used as
hosts for replication of bacteriophages Pf3 and Pf1, respec-
tively, and were originally obtained from ATCC. Strain PAK
was used as a source for PAK pili. E. coli strain K-12 JE2571
(FimFlaSmr Nalr Rif r) was used as a host for RP4 piliplasmids pML123 and pWP471, which when co-expressed in
this cell line generate a cell free from common pili or flagella
but with functional RP4 pili. E. coli JE2571 (pML123,
pWP471) was a kind gift from Dr. E. Lanka (Max-Planck-
Institut fu¨r Molekulare Genetik, Berlin, Germany). Bacterio-
phages Pf1 and Pf3 were supplied by Dr Linda Troeberg
(University of Cambridge, UK) and the expression plasmid
pfd8SHU has been described previously (Malik and Perham,
1996). Restriction enzymes were used as recommended by
their supplier (New England Biolabs). T4 DNA ligase was
purchased from Promega and Pfu DNA polymerase from
Stratagene.
Purification of bacteriophages and pili
Purification of bacteriophages Pf1 and Pf3 was as
described in Malik et al. (1996) except that P. aeruginosa
PAK was used as the host for Pf1 and strain PAO for Pf3.
RP4 pili were purified from E. coli JE2571 (pML123,
pWP471) (Lessl et al., 1993; Waters et al., 1992) using the
method described in Eisenbrandt et al. (1999). PAK pili were
purified using the method described by Paranchych et al.
(1979), PAO pili were a kind gift from Dr Randy Irvine
(University of Alberta, Canada). Purified pili and bacterio-
phage virions were analyzed by means of SDS-PAGE and
Western blot.
Construction of g3p expression plasmids
DNA fragments encoding Pf3 ORF483 (amino acid residues
1–378) and Pf1 ORF437 (amino acid residues 31–265) were
amplified by polymerase chain reaction (PCR) from the
replicative form DNA of bacteriophages Pf3 and Pf1, respec-
tively. The primers used for amplification of ORF483 were 5V-
TCCGCGCCGCGGGCTGGGCCTGTTTCTACAGAG-3V and
5V-AAAAAAAAGCTTCTAATGGTGATGGTGATGGTGA-
GAACCGGAACCAGAAGATGGCGG-3V; they were designed
to include an 5V-EcoRI site and a 3V-HindIII site after a sequence
encoding a 6xHis tag. Primers used for ORF437 amplification
were 5V-GGAGATGAATTCATGGGTCTACATTATTTAT-
TTGGG-3V and 5V-TTTTTTAGGCCTTTAGTGATGGTGATG-
ATGGTGCGGCGTGGTCGGGTCGG-3V designed to include a
5V-SacII site and a 3V-StuI site after a sequence encoding a 6xHis
tag.
Both constructs were ligated into appropriately digested
pfd8SHU vectors, thereby placing the subgene under the
control of the plasmid tac promoter and, in the case of ORF437
DNA, providing the encoded protein with the 23-residue leader
sequence of the g8p of bacteriophage fd to aid secretion of the
mature recombinant protein into the periplasm.
Expression of subgene and purification of rORF483 protein
E. coli TG1 recO cells transformed with the plasmid
encoding rORF483 were cultured in LB medium (Sambrook
et al., 1989) containing 100 Ag/ml ampicillin. Cultures were
induced at mid-log phase using 1 mM isopropyl-h-d-thioga-
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-C. The cells were harvested by centrifugation, the supernatant
was removed and the pellets were frozen at 20 -C.
Frozen pellets were thawed slowly at room temperature and
cell lysates prepared using Bug-Busteri with Benzonase
(Novagen UK) as detailed in the manufacturer’s instructions.
The cell lysate was then passed through a 0.45 Am syringe filter
before purification of the target protein using a XK16/10 FPLC
column (Pharmacia) containing 8 ml Qiagen Ni-NTA Super-
flow medium equilibrated with 50 mM NaH2PO4, 300 mM
NaCl, 10 mM imidazole buffer, pH 8.0. The column was
washed before the bound rORF483 protein was eluted by a
one-step procedure using 50 mM NaH2PO4, 300 mM NaCl,
250 mM imidazole buffer, pH 8.0. The resulting partially
purified rORF483 protein was then dialysed against 20 mM
potassium phosphate buffer, pH 6.3, at 4 -C before further
purification was undertaken by means of ion exchange
chromatography using a Pharmacia Hi-load Q column equil-
ibrated with potassium phosphate buffer, pH 6.3. rORF483
protein was eluted from the column using a continuous
gradient of 0.25–0.5 M NaCl in the same buffer and purified
samples were stored in 20 mM potassium phosphate buffer, pH
7.0. The identity of the protein was checked by means of
electrospray mass spectrometry (calculated mass 39,065 T 7
Da, expected mass 39,071 Da), amino acid analysis and N-
terminal sequence analysis (Protein and Nucleic Acid Chem-
istry Facility, Department of Biochemistry, University of
Cambridge).
Expression of subgene and purification of rORF437 protein
The plasmid encoding the rORF437 construct was trans-
formed into E. coli TG1 cells. Bacterial cultures were grown at
37 -C to mid-log phase, and protein expression was induced
with 1 mM IPTG (final concentration). After 3 h, the cells were
harvested by centrifugation. rORF437 protein was expected to
be released into the periplasm, and a protocol to recover protein
from this fraction was therefore used [as in The QIAexpressio-
nist handbook (Qiagen), protocol 11]. Most of the protein
accumulated as inclusion bodies in the cytoplasm, but the small
portion produced in the periplasm had the leader sequence
cleaved as expected, so this fraction was purified further.
The periplasmic protein recovered in lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) was first
purified by using a column of Ni-NTA resin (Qiagen). The
crude lysate was applied to the column and the protein was
eluted in the same lysis buffer containing 150 mM imidazole.
rORF437 protein was further purified using a Q-Sepharose
column (Pharmacia) equilibrated with 20 mM phosphate
buffer, pH 8.0. A continuous gradient between 0.1 and 0.5 M
NaCl in the same buffer was applied to recover the protein. The
purity of the protein was evaluated at every stage by means of
SDS-PAGE. The identity of the protein was checked by means
of MALDI-TOF mass spectrometry (calculated mass 25,573 T
4 Da expected mass 25,541 Da) and N-terminal sequence
analysis (Protein and Nucleic Acid Chemistry Facility, Depart-
ment of Biochemistry, University of Cambridge).Limited proteolysis of Pf3 virions
Bacteriophage Pf3 virions were mixed with subtilisin at a
ratio of 50:1 (w/w) and the total volume made up to 100 Al with
10 mM Tris–HCl buffer, pH 8.0. The mixture was incubated at
37 -C for 1 h with shaking. PMSF was then added to a final
concentration of 2 mM to inhibit the proteinase. Samples were
subjected to SDS-PAGE, blotted onto nitrocellulose and
stained with Coomassie Blue. N-terminal sequences were
determined for all visible bands. Infectivity was evaluated by
means of a p.f.u. plaque assay (Sambrook et al., 1989).
Biotinylation of Pf3 virions
Samples of bacteriophage Pf3 (3 mg/ml) were dialysed
against 50 mM sodium bicarbonate buffer, pH 8.5. Immedi-
ately before use, 1 mg of N-hydroxysuccinimidobiotin (NHS-
biotin) was dissolved in 75 Al DMSO and 25 Al of the solution
was added to the sample of bacteriophage. The mixture was
incubated at room temperature for 1 h on a shaking table before
excess NHS-biotin was removed by gel filtration using a
Pharmacia PD10 desalting column as described in the
manufacturer’s instructions. Biotinylated bacteriophage virions
were stored at 4 -C until ready for use.
The outcome of the biotinylation procedure was checked by
subjecting the biotinylated virions to SDS-PAGE and then
carrying out a Western blot using 200 ng/Al streptavidin–HRP
(Sigma) followed by the chemiluminescent substrate o-
phenylenediamine dihydrochloride (OPD, Sigma) to detect
the covalently attached biotin.
Production of antiserum to bacteriophage Pf3
Purified Pf3 bacteriophage virions were used as antigens in
two rabbits (work carried out by Cymbus Biotechnology). The
rabbits were injected with intact virions 3 times at 17-day
intervals, and blood samples were taken before the first and
then after each injection. The terminal bleed was 5 days after
the third injection. Antiserum was prepared from the blood
samples by centrifugation and stored at 80 -C.
Bacteriophage-pilus binding ELISA assay
Purified preparations of RP4, PAK or PAO pili (30 Ag/ml),
diluted in PBS, were immobilized onto plastic plates by
overnight incubation at 4 -C. Non-specific binding sites were
blocked with 2% (w/v) non-fat milk powder (Difco) in PBS
(block buffer) at room temperature for 2 h with shaking. Either
bacteriophage virions (10 Ag/ml) or rORF483/rORF437 protein
(3 AM) were then applied (in block buffer) and the plate was
incubated at room temperature for 1 h. Bound proteins were
detected using anti-Pf3/Pf1 antiserum (1:1000 dilution in block
buffer) followed by secondary antibody-HRP conjugate (Sig-
ma) at 1:5000 dilution in block buffer. OPD was used as the
substrate and absorbance was measured at 450 nm. All
determinations were in triplicate and each ELISA was repeated
a minimum of three times.
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For the bacteriophage Pf3 competition assay, purified RP4
pili (10 Ag/ml in PBS) or BSA (2% w/v) was immobilized
overnight onto plastic plates and, after a 1 h non-specific
blocking step using 2% (w/v) BSA (Sigma) in PBS, different
concentrations of wild-type Pf3 virions (non-biotinylated),
wild-type fd virions or rORF483 were mixed with 5 Ag/ml of
biotinylated Pf3 virions [in 2% (w/v) BSA (Sigma) in PBS]
and applied to the plate. Following incubation for 1 h at room
temperature, the bound biotinylated virions were detected using
a 1:5000 dilution of a streptavidin–HRP conjugate (Sigma).
For bacteriophage Pf1, purified PAK pili (10 Ag/ml in PBS)
were immobilized overnight onto plastic plates and, after a
non-specific blocking step [1 h in 2% (w/v) non-fat milk
powder (Difco) in PBS (block buffer)], different concentrations
of wild-type Pf1 or Pf3 virions were mixed with 2.5 AM
rORF437 protein in block buffer and applied to the plate.
Bound rORF437 protein was detected using an anti-pentahis
antibody (Qiagen) which was in turn detected using anti-rabbit
HRP-conjugated antibody (Sigma) with OPD as the substrate.
Plates were read at A450.
In all cases, three determinations were carried out for each
sample and each ELISA was repeated a minimum of three
times.
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